ARCT as of Oct 31 · 19:36 ET
ARCTNasdaqPharmaceutical Preparations

Arcturus Therapeutics Holdings Inc. · Brief

Next report

9 days

Nov 9 · after closeest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±14.0%
avg realized
±9.7%
Nov 7 '24±10.9%▲+4.72%×0.43
Mar 6 '25±14.7%▼−8.89%×0.60
May 12 '25±9.5%▲+2.33%×0.24
Aug 11 '25±10.2%▲+30.73%×3.03
Q3 FY25±10.9%▼−1.25%×0.11
Q1 FY26±18.3%▼−4.17%×0.23
May 7 '26±15.5%▲+3.60%×0.23
Q2 FY26±21.8%▲+21.88%×1.00
quarterimplied−35%0+35%realized×
Q2 FY26±21.8%▲+21.88%×1.00
May '26±15.5%▲+3.60%×0.23
Q1 FY26±18.3%▼−4.17%×0.23
Q3 FY25±10.9%▼−1.25%×0.11
Aug '25±10.2%▲+30.73%×3.03
May '25±9.5%▲+2.33%×0.24
2 older reports
Mar '25±14.7%▼−8.89%×0.60
Nov '24±10.9%▲+4.72%×0.43
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2 of 3

3disclosed supplier and customer ties in SEC filingsSEC filings
135managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

6 of 8recent reports where the move came in under the options implied rangeEarnings history
8 of 24largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ARCT report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±16.9% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.